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Abstract
Frozen shoulder (adhesive capsulitis) is a common, painful and disabling condition which is typically slow to resolve.
Patients with this condition will be seen in every musculoskeletal practitioner’s clinic on a regular basis.  There is a wide
variety of treatment modalities available, some more effective than others.  This article reviews the literature on the
aetiology and natural history of the condition, and the common treatments provided.  The literature on hydraulic arthrographic
capsular distension (hydrodilatation) is reviewed and six cases referred for this treatment from a chiropractic clinic are
presented.
Background
Since first described as peri-arthritis scapulo-humerale by
Duplay in 1872, the condition commonly known as frozen
shoulder continues to present a clinical conundrum for
practitioners1.  In 1934 Codman labelled the condition “frozen
shoulder” and postulated that the underlying pathology was
tendonitis of the rotator cuff.  Codman went on to state that
frozen shoulder constituted “a class of cases which are
difficult to define, difficult to treat, and difficult to explain
from the point of pathology”2.  Over the years this painful
and disabling condition has been known varyingly as:
adhesive capsulitis, restrictive periarthritis, Duplay disease,
frozen shoulder, frozen shoulder syndrome, scapulohumeral
periarthritis, adhesive bursitis, obliterative bursitis and
arthrofibrosis3.  For the purposes of this paper the term frozen
shoulder(FS) will be used.  While FS has a significant impact
on the perceived health status of those afflicted4,5,
unfortunately for both the patient and practitioner Codman’s
statement largely remains true to this day, which led Bunker6
to propose a new term to describe the condition.  Bunker
suggests ‘HGAC’ with a double meaning: “humeroglenoid
acromioclavicular syndrome” for the patient and “haven’t
got a clue” for the doctor.
Definition
Primary (idiopathic) FS may be defined as idiopathic shoulder
pain of at least one month duration accompanied by
increasingly severe limitation of active and passive
glenohumeral movements in all ranges of motion in persons
who have no identifiable general illness and whose
radiographs are entirely normal7.  Secondary FS is clinically
indistinguishable from primary FS, however in secondary FS,
an identifiable disorder such as a rhematological or
neurological disease is present8 or other potential predisposing
factors as listed below.  Zuckerman and Cuomo subdivided
secondary FS into intrinsic, extrinsic and systemic categories9.
Prevalence
FS affects approximately 2 percent of adults, usually between
ages 40 and 65 and affects more women than men10 and
appears to be more prevalent in patients with heart disease11.
Although rare, FS has been reported in children12 and in
identical twins13.
FS is found in 10 - 20 percent of diabetics and the incidence
appears to be increasing along with that of diabetes14.  Within
the diabetic population, separation of the diabetic patients
into type I and type II diabetics reveals a prevalence of 16
percent and 7 percent, respectively.  An increased prevalence
of FS was noted in female patients as well as those who had
a longer duration of diabetes mellitus however the incidence
does not appear to be associated with long-term glycemic
control.10
Potential Predisposing Factors
Although no etiological studies have been performed, several
potential predisposing factors have been identified in FS,
including:
• diabetes10,14
• pulmonary tuberculosis15
• scleroderma15
• a period of enforced immobility resulting from
trauma, overuse injuries or surgery16-18
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• medication: fulnarizine19, matrix metalloprotinase
inhibitor20, protease inhibitors21,22
• hyperthyroidism23,24
• genetic predisposition25
• Dupuytren’s disease26,27
• elevated serum lipids28
• heart disease11
• neurotic personality29
While none of these predisposing factors have been formally
proven and at least one, neurotic personality, has been
refuted30 most have sufficient anecdotal evidence to be
considered when interviewing a patient with suspected FS.
Natural History
It is commonly believed that FS is a self-limiting syndrome
divided into three consecutive stages lasting approximately
18 months in total31,32.  These stages are: pain, stiffness and
recovery.  Studies have shown the duration of the disorder to
be far more protracted. In a prospective study involving 49
FS patients over a 5-10 year period, Reeves33 found that the
time to greatest recovery was an average total of 30.1 months
and in 30 percent of patients the second shoulder became
similarly affected 6 months to 7 years after the first with the
second event following a similar chronology to the first.
Shaffer34 conducted a prospective study on 62 FS patients
and found that 30 percent of subjects had a measurable
reduction in motion at an average of 7 years review.
Staging
Stage 1 - Painful stage: 2 - 9 months.  During this stage the
patient experiences increasing pain with movement and pain
is often worse at night.  There is progressive loss of motion
with increasing pain.  The pain often becomes disabling and
has a significant effect on activities of daily living.
Stage 2 - Adhesive or Stiffness stage: 4 - 12 months.  During
this stage pain begins to diminish, and moving the arm is
more comfortable although range of motion is greatly
reduced, often as much as 50 percent less than the other arm.
Stage 3 - Recovery stage : 12 - 42 months.  The condition
begins to resolve with gradual restoration of motion.  In
general the longer the stiffness phase, the longer the recovery
phase.  In over 50 percent of patients some restriction of
motion remains even after greatest recovery but only in a
small percentage is this restriction a handicap.33
Pathophysiology
The cause of FS has yet to be identified. Radiographs are
essentially normal.  There are no signs of systemic
inflammatory disorder, and other joints remain unaffected.
Laboratory tests yield no useful answers. ESR and C reactive
protein are not elevated.  Tests for immunologic components
such as RF, antinuclear antibodies and autoantibodies to
smooth muscle, collagen, or cartilage are negative and the
frequency of HLAB27 is not increased among FS patients.
No known infectious agent has been identified.35
Neviaser and Neviaser described FS as “primarily an
inflammatory reaction in the joint capsule that subsequently
leads to the formation of adhesions in the axillary fold”.  They
described four stages of FS.  Stage 1 was labelled the pre-
adhesive stage in which there is a fibrinous synovial
inflammatory reaction only demonstrable by arthroscopy.
Stage II was marked by acute adhesive synovitis with a
proliferative synovitis and early adhesion formation.  In Stage
III, (the stage of maturation) there is less synovitis with loss
of the axillary fold.  Stage IV they labelled the chronic stage
in which adhesions in the axillary fold are fully mature and
may in fact obliterate this structure.36
Hannafin37 described the arthroscopic findings during three
stages of FS as follows:
Stage 1 findings: diffuse glenohumeral synovitis,
hypertrophic, hypervascular synovitis, rare inflammatory cell
infiltrates and a normal underlying capsule.
Stage 2 findings: diffuse, pedunculated synovitis, tight capsule
with rubbery feel on insertion of the arthroscope,
hypertrophic, hypervascular synovitis with perivascular and
subsynovial scar, significant fibroplasia and scar formation
in the underlying capsule.
Stage 3 findings: no hypervascularity, remnants of a fibrotic
synovium visible.  The capsule feels extremely dense and
thick on insertion of the arthroscope and there is a diminished
capsular volume.
Recent studies have shown the histological and
immunocytochemical findings in FS to be very similar to those
in Dupuytren’s disease of the hand, with no inflammation
and no synovial involvement26.  Contracture of the
coracohumeral ligament acts as a check rein to passive
glenohumeral movement and external rotation26,38.  Later work
by Bunker39 demonstrated that in patients with FS there is an
absence of metalloproteinase-14 when compared to controls
which may lead to chronic fibrosis of the joint capsule.
Müller tested the hypothesis that FS syndrome is a reflex
sympathetic dystrophy.  Müller found several similarities
between FS syndrome and an algoneurodystrophic process
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including progressive decreased bone mineral density in the
affected humerus in comparison to the non-affected side,
increased uptake in affected areas in both diseases on
radioisotope bone scan, dull night pain, idiopathic and post-
traumatic causes and reduced skin temperature in affected
areas as demonstrated by thermography.8  It is worth noting
that there is some controversy surrounding the nature of reflex
sympathetic dystrophy and whether it is a primary organic
disorder or a primary psychogenic disorder associated with
achieving some secondary gain40.
Diagnosis
History and Examination
History and physical examination form an important basis
for clinical decision-making.  While knowledge of a patient’s
history does not appear to influence the reliability of clinical
tests, such knowledge does focus testing and produces an
increased prevalence of positive findings41.  Patients with a
history of worsening shoulder pain with loss of motion of 1
month duration and a physical examination confirming loss
of active and passive glenohumeral joint motion may be
considered to fit the criteria for FS.  Physical examination of
such patients should include inspection and palpation of the
joints of the shoulder girdle, examination of the cervical spine,
range of motion assessment of the shoulder girdle, and
provocative testing7,42.
Imaging
If imaging evaluation is contemplated, studies should
generally be limited to routine shoulder radiographs.  Plain
film radiography may be performed initially to assess the
glenohumeral joint and subacromial space and to rule out
frank pathologies such as calcific tendonitis37.  The joints
should be normal or show minimal age-related changes7,35.
Bone mineral density may be reduced in the proximal
humerus in female sufferers but this appears to resolve over
time and is not clinically significant8,43,44.  Some authors have
suggested that the diagnosis of FS “must be confirmed by
arthrography because it is the most effective means of
differentiating the stiff and painful shoulder from an adhesive
capsulitis”37 and others have suggested that arthrography is
very useful in distinguishing between idiopathic and
secondary adhesive capsulitis45,46.  However, arthrography is
an invasive procedure with concomitant risks and it is the
opinion of the authors that the use of arthrography for
diagnosis of FS is somewhat old school and that the diagnosis
of FS is readily made at clinical examination by a practitioner
skilled in musculoskeletal examination.
Dynamic sonography has been suggested as a valuable tool
for diagnosing adhesive capsulitis.  In a study involving 23
patients with confirmed adhesive capsulitis at arthrography,
21 showed limitation of movement of the supraspinatus
tendon against the acromion of the scapula on sonographic
examination.  The study found a sensitivity of 91%, specificity
of 100% and an accuracy of 92%.  The authors suggest that
dynamic sonography is a reliable technique for the diagnosis
of FS.47
The clinical utility of MRI in evaluating patients with FS
remains unclear.  Emig48 reported that a joint capsule and
synovium thickness greater than 4 mm was a useful criterion
for the diagnosis of FS.  Manton49 reported that capsular/
synovial thickness and static fluid volume are inconclusive
as MR arthrographic signs for establishing a diagnosis of FS
while Lee50 reported that MR arthrography appears to yield
useful results for the diagnosis of FS.  Connell51 compared
MRI and surgical findings in a group of patients who
underwent surgery for adhesive capsulitis and concluded that
MRI can identify alterations in the shoulder joint that
correspond to abnormalities seen at surgery and therefore
MRI may be useful for discriminating adhesive capsulitis from
other shoulder abnormalities.  These findings are similar to
Carrillon’s who reported that MR imaging with gadolinium
injection can contribute to the diagnosis of idiopathic FS in
difficult cases52.
Differential Diagnosis
Several conditions have been reported to produce shoulder
pain and stiffness.  These should be kept in mind when
evaluating the patient with suspected FS.  Spindler and
Dovan42 described the following conditions which may cause
symptoms similar to FS:
• referred pain from
• cervical spine
• subdiaphragm
• ribs
• sternoclavicular joint
• acromioclavicular joint
• fracture of the distal clavicle
• glenohumeral joint and associated structures
• rotator cuff lesions
• subacromial space pathology
• bicep tendon lesions
• impingement syndrome
• joint instability
• g/h joint dislocation
• labral tears
Less common conditions which have been known to cause
symptoms similar to FS are:
• neoplasms53
• pneumonia54
• neuralgic amyotrophy25
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Objective Measures
Several objective tools have been developed to assess
shoulder disability and response to treatment.  In this series
the Simple Shoulder Test was chosen because of its ease of
use for both patients and practitioners.
Simple Shoulder Test
The Simple Shoulder Test (SST) was developed by the
University of Washington Shoulder and Elbow Service as a
standardised way of recording shoulder function before and
after treatment.  The short test requires patients to answer
‘yes’ or ‘no’ to twelve questions derived from the common
complaints of persons suffering from shoulder pain.  The SST
is simple to administer and has demonstrated a high degree
of reproducibility and face validity55,56.  The SST has been
shown to be reliable57,58 and responsive to successful treatment
of FS58,59.
(The SST is distributed free of charge via the internet and
may be obtained at:  http://www.orthop.washington.edu/
shoulder_elbow/technical/shouldertest)
Treatments
Some authors state that pain relief is the main objective of
all treatments for FS60.  However, considering the protracted
nature of this disorder and its impact on patients’ functionality,
this objective should be refined to early pain relief and
functional restoration61.  The literature is rife with studies
reporting on the many treatments for FS.  Searches were
conducted in MEDLINE, CINAHL and ACMD up to June
2004 using the search terms: frozen shoulder, adhesive
capsulitis, treatment, diagnosis, hydrodilatation, and
distension arthrography.  Table I summarises the FS
treatments and outcomes reported in the retrieved literature.
Evident from this table is the wide variety of treatments
reported.  These range from a program of rest, analgesia and
gentle exercise to open surgical release.  It is important to
note that overly vigourous exercises or physical therapy can
be counterproductive37.  Aggressive techniques such as
glenohumeral joint manipulation under anaesthesia and open
capsulotomy are not without significant risk and should be
reserved for the most refractory cases which have failed to
respond to less invasive approaches however, there is little
evidence to show that such an approach will alter the natural
course of FS86.  Combining supervised physiotherapy with
intraarticular steroid injection and home exercises may
provide faster improvement in shoulder range of motion
however, physiotherapy alone appears to be of little value in
the management of FS74.  Treatment outcomes appear to be
less satisfactory in patients with diabetes10,14,80,101 or when
treatment is covered by workers’ compensation113.  It is
beyond the scope of this paper to review all FS treatments.
Readers are directed to the 2004 Cochrane Review of
Interventions of Shoulder Pain for the evidence of
effectiveness of FS treatments including hydrodilatation114.
The reviewers concluded that there is little evidence to support
or refute the efficacy of common interventions for shoulder
pain including FS114.  In addition, they concluded that there
is a need for further well designed clinical trials and that
more research is needed to establish a uniform method of
defining shoulder disorders and developing outcome
measures which are valid, reliable and responsive in these
study populations114.
Choice of treatment approach depends upon the patient’s
functional status at the time of presentation.  Generally
speaking a trial of conservative care is warranted provided
the clinician closely monitors progress.  If progress stalls or
the condition worsens, an alternate approach to treatment
should be considered115.
This was the approach taken with patients in this case series.
All patients had been symptomatic for several months and
had failed to respond to a course of physiotherapy prior to
referral for hydrodilatation.
The 2004 Cochrane Review of Interventions for Shoulder
Pain uncovered no trials of hydrodilatation for FS which met
the four criteria for inclusion in the review114.  There were
studies which partially met the criteria but were excluded
because of some deficiencies.  The following studies were
excluded but are worth considering here.
Hsu and Chan89 reported a prospective study comparing
manipulation under anaesthetic and physiotherapy with
arthroscopic distension and physiotherapy, and with
physiotherapy alone in patients with FS.  The authors found
that there was no significant difference between distension
and manipulation groups in terms of pain, range of motion or
function.  They reported that clinically, arthroscopic
distension offers advantages in terms of less risk of fracture,
and affords the opportunity to view the shoulder joint and
assess for rotator cuff pathology.  This study was not included
in the Cochrane Review because it was not a randomised
trial114.
Jacobs et al103 compared three FS interventions in a
prospective randomised trial.  Shoulder distension with air,
intra-articular steroid injection, and distension with air and
steroid.  The authors found intra-articular steroid injection
and distension with steroid to be superior to distension alone,
but found no significant difference between steroid with
distension, and intra-articular steroid injection without
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distension.103  The Cochrane reviewers excluded this study
because changes in pain were reported for the whole
population and not by treatment group, and improvement in
range of motion and strength was reported by group as a
mean change, but with no baseline scores and no standard
deviations114.
Corbeil et al104, conducted a double-blind prospective study
which compared intraarticular injection of steroid (n=20) vs
hydrodilatation (n=25) and found no significant difference
between the two groups.  More than 80% of the patients who
were experiencing pain at rest and nocturnal pain improved
under both treatment regimes104.  However, because Corbeil
et al failed to define ‘adhesive capsulitis’, failed to report
standard deviations and ‘p’ value and there was no description
of how passive motion of the scapulohumeral joint was
measured the study was excluded from the Cochrane
Review114.
In a paper published subsequent to the aforementioned 2004
Cochrane Review, Buchbinder et al107 reported on their
randomised, double blind trial comparing placebo to shoulder
joint distension with normal saline plus corticosteroid.  In
this study involving 48 subjects the hydrodilatation group
demonstrated significantly greater improvement in pain and
disability measures over placebo107.
It seems that the more rigid the shoulder is at the time of
hydrodilatation, the less likely it is that full movement will
be restored101.  However, even if rigidity is unchanged
following hydrodilatation, pain relief is still achievable101.
Hydrodilatation
Hydrodilatation or as it is more accurately known, distension
arthrography, generally involves inserting a needle into the
joint capsule under local anaesthesia using fluoroscopic
control and dilating the contracted joint capsule with a mixture
of long acting anaesthetic, cortisone and saline97.  Some
studies have used air instead of saline92 while others have
excluded the use of steroid102.  However, hydrodilatation with
air results in a “squelch” when the shoulder is subsequently
moved103 which patients find unpleasant.  Furthermore, it is
the experience of one of the authors (RB) that because of the
inherent compressibility of air, distension of a contracted
capsule is more difficult that if saline is used.
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Table I: Summary of Treatments and Outcomes
Treatment Outcome  References 
1.  rest, analgesia, motion 
exercises, moist heat 
Equal to natural history. Too rapid an increase in activity may prolong the disorder.  5, 62, 63, 
65. 
2. physiotherapy  and 
mobilization 
Lacks good clinical studies. Overly aggressive mobilization may prolong the disorder.  64-70. 
3.  oral corticosteroids  Decrease in pain but no change in range of movement.  71. 
4. corticosteroid  injection  Usually decreased pain but not much improvement in range of movement. Pain relief 
is moderate: subacromial injection may be as effective as intra-articular injection. 
72-75. 
5. glenohumeral  joint 
manipulation under 
anaesthesia with and 
without steroid injection 
Marked improvement in range of movement. Adverse outcomes include humerus 
fracture, g/h joint dislocation, neurovascular injury, articular cartilage injury. 
Significant post-procedure pain reported. 
10, 61, 76-
81. 
6. arthroscopic  capsular 
release 
Marked improvement in range of movement. Significant post-procedure pain 
reported. High failure rate among diabetics. Reserved for refractory cases. 
31, 80, 82-
84. 
7.  open surgical release  Good improvement in range of motion. Reserved for FS cases which have failed to 
respond to less invasive procedures. Should be used with caution in insulin dependent 
diabetics. 
80, 85, 86. 
8. suprascapular  nerve 
block with intra-articular 
injections 
Reduction of pain and increase in range of movement. No controlled clinical studies 
performed. 
87. 
9,10.capsular hydrodilatation 
with and without steroid 
injection, and with 
TENS 
Significant pain reduction and moderate improvement in range of movement. The 
procedure is moderately painful. Significant reduction in procedural pain is reported 
with the use of TENS during hydrodilatation. FS stage may be important in predicting 
degree of improvement. 
73, 76, 88-
107. 
11. Japanese  herbal 
medicine 
Improvement in range of movement in 2 patients. Lacks any good clinical studies.  108. 
12.  Bowen technique  Lacks good clinical studies.  109. 
13. acupuncture  and 
exercise 
Randomized controlled trial with 35 patients. Improved functional mobility and 
decreased pain in treatment group. 
110. 
14.  osteopathic treatment  Pilot study comparing osteopathic treatment and physiotherapy. Both improved range 
of motion and gave pain relief. 
111. 
15.  chiropractic treatment  Single case report. Lacks good clinical studies.  112. 30
In the series by Bell et al101, distension was continued until
capsular rupture occurred.  Dependant upon the contracted
state of the joint capsule, this usually occurred when between
10 ml and 55 ml of normal saline had been injected.  On
occasion, rupture was not achieved until 100 ml had been
injected.  Rupture usually occurred through the subscapularis
bursa and occasionally down the bicep sheath.  In some cases,
the pain of the procedure was so severe that it had to be
terminated before capsular rupture was achieved101.  Rizk
reported that pain relief was not achieved when rupture
occurred at the distal bicipital sheath94.
For shoulder arthrography a posterior approach to the
shoulder is preferred.  Typically the axillary pouch is fibrosed
in FS making an anterior approach technically more difficult.
It has also been our experience that a posterior approach is
more readily tolerated by the patient.
In our series the procedure was performed by one of the
authors (RB), a skilled radiologist.  Initially, skin anaesthesia
was performed using a sterile technique and a 22 gauge spinal
needle passed into the joint under fluoroscopic control.
Needle position was confirmed by injection of 5 ml of non-
ionic contrast material (Omnipaque 300) (see figure I).  This
was followed by 5 ml of Marcain long acting anaesthetic and
2 ml of Celestone Chronodose.  Twenty to 30 ml of
refrigerated sterile saline was then instilled, making 42 ml
the maximum total injected volume into the shoulder joint.
Even though capsular rupture was not the clinical objective
in our series, evidence of rupture down the bicep tendon
sheath is noted in figure II.
Case Reports
Over an eight month period, four patients attending a
chiropractic clinic were diagnosed with FS.  The diagnosis
was made based on their history and physical examination
findings.  Each patient was referred for hydrodilatation
treatment.  Where practical, a Simple Shoulder Test was
administered prior to hydrodilatation and at varying intervals
following.
1)  74 Year Old Male
SV, a 74 year old male was referred by a general medical
practitioner for treatment of left shoulder pain.  SV had been
suffering severe left shoulder pain since suffering a CVA with
left sided hemiparesis 13 months previously.  He had no prior
history of shoulder pain.  There was point tenderness over
the greater tuberosity of the left humerus.  Passive range of
motion was grossly reduced and painful in all ranges of
glenohumeral motion.  An SST was not administered for
obvious reasons.  SV’s shoulder pain interfered with sleep
while the reduced range of movement presented difficulties
in personal hygiene and dressing.  Crepitus was noted in the
glenohumeral joint in the limited range of movement
available.  Plain radiographs of the left shoulder demonstrated
degenerative sclerosis of the upper cortex of the greater
tuberosity of the humerus.  No soft tissue calcification was
present.  Minor degenerative lipping was present in the
glenohumeral joint.  The acromioclavicular joint was normal.
Previous treatment consisted of physiotherapy and
occupational therapy three times per week for most of the
prior 12 months with no resultant increase in range of
movement or diminution in pain.  SV was considered a
candidate for hydrodilatation treatment.  This was performed
using 8 ml of Marcain, 2 mls of 2% Lignocaine, 5 ml of
contrast material and 2 ml of Celestone chronodose.  A further
5 ml of saline was then injected.  The joint capsule remained
intact.  There were no complications noted at the time of
procedure.
“Amputated” axillary recess
Figure I.  Pre-distention contrast
Contrast injection confirming intraarticular needle position, intact
rotator cuff and contraction of the joint capsule.  Note the loss of the
normal axillary recess of the joint capsule and lack of contrast over
the lateral half of the humeral head with early filling of the long head
of biceps tendon sheath.
Long head of biceps tendon sheath
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The immediate result was a marked improvement in
glenohumeral joint movement in all ranges.  SV reported that
the procedure was quite uncomfortable but that he had slept
through the night without being awakened with shoulder pain
for the first time since his CVA.  SV received physiotherapy
treatment at the local hospital for three weeks following the
hydrodilatation procedure.  He chose to cease these treatments
because of the discomfort involved and lack of obvious
improvement in shoulder range of motion.  SV attended the
chiropractic clinic for seven treatments over a four month
period after which he was discharged from care.  Treatment
consisted of 6 minutes of ultrasound (2.5 wcm2 @ 45%) to
the glenohumeral joint, mobilisation of the glenohumeral joint
and the scapulothoracic joint followed by 10 minutes of moist
heat application (HeatTreat™).  There was a gradual increase
in range of movement during the first two months of treatment
to approximately 50% of normal.  SV’s range of motion did
not change in the ensuing two months.  SV’s sleep remained
undisturbed by shoulder pain and there was a marked
improvement in the ease with which he and his carer were
able to perform his normal daily activities related to hygiene
and dressing.
2)  39 Year Old Female
PW, a 39 year old female process worker was referred by a
general medical practitioner for management of shoulder pain
of 3 months duration involving her dominant left side.  Onset
was insidious.  Prior history included a work related rotator
cuff injury approximately 9 years previously resulting in a
residual reduction in range of motion but no significant
reduction in functionality.  The presenting left shoulder pain
was deemed by her general medical practitioner to be work
related and consequently hers was a workers’ compensation
case.  Examination revealed grossly restricted and painful
active and passive ranges of left glenohumeral joint motion.
Plain radiographs revealed calcification in the subscapularis
tendon which was believed to be related to the previous injury.
PW answered ‘no’ to questions 11/12 on the initial SST
evaluation.  PW rated her shoulder pain as 9/10 on a 10 point
VAS.
PW was taking prescription NSAIDs and had been receiving
physiotherapy treatment for six weeks prior to presentation
without an increase in range of motion or decrease in pain.
PW was referred for hydrodilatation which was performed
using 12 ml of saline, 2 ml of 0.5% Marcain and 1 ml of
Celestone Chronodose.  No immediate complications were
noted at the time of procedure.
PW was reviewed the day following the procedure.  She
reported that the although the procedure itself was quite
painful, she had experienced an immediate reduction in
shoulder pain and that she had slept well the night of the
procedure.  Both active and passive ranges of glenohumeral
joint motion were increased by approximately 60%.  PW was
treated using a combination of ultrasound (3wcm2 @ 50%),
glenohumeral joint mobilisation, interferential current (80 -
160 Hz continuous) to the glenohumeral joint and cervical
spinal manipulation.  In addition PW was given a home
exercise program of stretching, light resistance band exercises
and heat treatment (HeatTreat™).  PW returned to modified
work duties after the first week of the procedure.  These duties
were increased to pre-injury status within one month of the
procedure.  After six weeks PW’s range of motion was near
full with some grabbing shoulder pain noted when working
overhead or moving the arm rapidly.  A second SST was
administered at this time.  PW answered ‘yes’ to 11/12.
Twelve weeks post-procedure PW returned to her general
medical practitioner complaining of residual shoulder pain
(VAS 3/10) and was subsequently referred for physiotherapy
treatment under workers’ compensation.
Note the appearance of the normal axillary recess of the joint capsule
and the presence of contrast over the lateral half of the humeral head
with filling of the long head of biceps tendon sheath.
Figure II.  Distended joint capsule
Intracapsular portion of
long head of biceps
tendon
Axillary recess
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3)  49 Year Old Male
SO, a 49 year old security officer who worked in a hospital
setting had been attending for supportive chiropractic care
since 1991.  In August 2001, during the course of a regular
consultation, he mentioned that he was experiencing right
shoulder pain which had been diagnosed as an impingement
syndrome and was being treated by the hospital’s
physiotherapist.  Three months later, when SO next attended
for chiropractic care, he was questioned about his shoulder
and indicated that he continued to have physiotherapy but
that the condition was not improving.  SO’s shoulder was
examined and he was found to have severely and painfully
restricted active and passive range of glenohumeral joint
motion.  An SST was administered and SO answered ‘no’ to
all twelve questions.  It was suggested that the diagnosis of
impingement syndrome was incorrect and that he in fact was
suffering with FS.  He was referred for hydrodilatation
treatment at the hospital where he worked to be followed by
physiotherapy.  SO reported that the procedure was very
painful but that he experienced immediate and lasting relief
from his shoulder pain and a marked increase in both passive
and active shoulder movement.  He curtailed the
physiotherapy after eight weeks because of the pain caused
by that treatment and the apparent lack of progress.  Twelve
months following the procedure his right shoulder range of
motion was full and he was unrestricted in his activities.  An
SST was administered at this time and SO answered ‘yes’ to
all twelve questions.  At this time, and for no apparent reason,
he developed FS on the left side.  An SST at this time yielded
‘no’ answers to 11/12 questions.  SO was referred for
hydrodilatation treatment without any post-procedure
treatment.  As he had experienced with the first
hydrodilatation, the procedure was very painful but there was
an immediate and significant reduction in his shoulder pain
and a marked increase in range of movement.  An SST
administered at 4 weeks yielded ‘yes’ answers to 9/12
questions.  Twelve months later and with no post-procedure
physiotherapy, the range of movement in the second shoulder
remains full and he is performing all activities involving his
shoulders without restriction.  Affirmative answers are given
to all 12 SST questions.
4)  49 Year Old Female
SA, a 49 year old florist, presented with a chief complaint of
insidious onset pain and restricted movement in her non-
dominant left shoulder.  The problem had been present for
six months. An initial SST yielded negative answers to 11/12
questions.  There was no prior history of such pain.  SA had
been receiving physiotherapy treatment for a period of six
weeks however her shoulder condition continued to worsen.
Examination revealed painful and severely restricted active
and passive glenohumeral joint movement in all ranges.  Plain
radiographs revealed no bony or articular abnormality.  There
was no capsular soft tissue calcification demonstrated.
SA was referred for hydrodilatation treatment.  This was
performed in accordance with the procedure described above
and shown in Figures I & II.  SA kept detailed diary notes for
the first seven days following hydrodilatation treatment.  The
procedure was described as very painful.  She was acutely
aware of the increasing pressure and intensifying pain in her
shoulder as hydrodilatation proceeded.  The procedure was
terminated at the point when she felt as though her shoulder
“was at explosion level”.  When she sat up after the procedure
there was a feeling of a weight falling down her arm but,
even though her arm felt “heavy”, her shoulder “had a sense
of freedom”.  Examination immediately following
hydrodilatation showed greatly increased passive and active
ranges of glenohumeral joint motion.  These increases were
present in all ranges and the movements did not elicit the
severe grabbing pain which had been present prior to the
procedure.  During the following eight hours SA’s arm pain
increased but was manageable with OTC analgesics.  She
reported sleeping for 5 hours continuously and awaking the
next morning “absolutely pain free” and with no feeling of
heaviness in her arm.  SA experienced undisturbed sleep for
up to 9 hours per night following the first night.  Over the
course of the first week SA attended clinic for three treatment
sessions which involved interferential current to the
glenohumeral joint (100-160 Hz continuous - 15 minutes),
mobilisation of the glenohumeral joint, cervical spine
manipulations and application of moist heat to the
glenohumeral joint (HeatTreat™ 15 minutes).  A home
rehabilitation program was devised which included shoulder
stretches, and moist heat application.  SA was instructed to
perform the stretches twice daily.  One month later, resistance
work (yellow Thera-Band™) and pulley work were
introduced.  An SST was administered at this time.  This test
yield ‘yes’ answers to 8/12 questions while ‘no’ answers were
given to 4/12 questions.
Over the course of the year following hydrodilatation, SA’s
shoulder range of motion continued to improve with external
humeral rotation being the last range to approach that of her
other shoulder.  There was a slight loss of motion in all ranges
and some shoulder pain following a minor motor vehicle
accident eight months after the procedure.  These symptoms
fully subsided within two weeks.  SA reported that she ceased
performing pulley exercises after about three months because
they seemed to be causing some residual shoulder pain.  At
the last follow-up, twenty-three months following
hydrodilatation, SA reports that she is performing all activities
without restriction.  The only residual symptom is a feeling
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of weakness in her left shoulder when working with her arms
overhead.  This has necessitated modifying her lifestyle
somewhat but is not perceived as a disability.  An SST at this
time yielded ‘yes’ answers to all questions but one.
Discussion
The literature on FS reveals that it is a relatively common
disorder which, left untreated, will result in significant pain
and disability for a period of up to 42 months after onset.
Treatments for FS reported in the literature range from a
program of rest, analgesia and motion exercises to open
surgical release.  The available literature is not overly helpful
in assisting clinical decision making with regard to FS
treatment.  The Cochrane reviewers determined that no
conclusions can be drawn regarding the efficacy of the
interventions studied for adhesive capsulitis114.  It is worth
noting however, that Buchbinder et al107 have published a
randomised, double blind placebo controlled trial which
supports the use of hydrodilatation for FS and that there are
at least 21 other studies reporting on over 700 shoulders which
draws one to conclude that hydrodilatation is safe, yields
immediate and lasting results in terms of pain relief and
improved ranges of motion and is a cost-effective intervention
in the management of FS.
The case series presented supports the position that
management of the frozen shoulder using capsular
hydrodilatation can reduce FS pain immediately and reduce
disability from a period of months to a period of weeks.  As
primary contact practitioners, chiropractors are well placed
to effectively contribute to the management of FS cases by
correctly diagnosing and recommending the appropriate early
intervention.
References
1 Duplay ES.  Dr la peri-arthrite scapulo humerale et des raideurs de
l’epaule qui en son la consequence.  Arch Gen Med 1872; 20:5131-
42.
2 Codman EA.  The Shoulder.  Thomas Todd, Boston 1934.
3 Rizk TE, Pinals RS.  Frozen Shoulder.  Semin Arthritis Rheum 1982;
11(4):440-52.
4 Gartsman GM, Brinker MR, Khan M, Karahan M.  Self-assessment
of general health status in patients with five common shoulder
conditions.  J Shoulder Elbow Surg 1998; 7(3):228-37.
5 O’Kane JW, Jackins S, Sidles JA, Smith KL.  Simple Home Program
for Frozen Shoulder to Improve Patient’s Assessment of Shoulder
Function and Health Status.  J Am Board Fam Pract 1999; 12(4):270-
7.
6 Bunker TD.  Time for a new name for ‘frozen shoulder’.  Br Med J
1985; 290(6477):1233-4.
7 Pearsall AW, Speer KP.  Frozen shoulder syndrome: diagnostic and
treatment strategies in the primary care setting.  Med Sci Sports Med
1998; 30(4 Suppl):s33-9.
8 Müller LP, Müller LA, Happ J, Kerschbaumer F.  Frozen shoulder: a
sympathetic dystrophy?  Arch Orthop Trauma Surg 2000; 120:84-7.
9 Zuckerman J, Cuomo F.  Frozen Shoulder in The shoulder: a balance
of mobility and stability: Workshop, Vail Colorado, September 1992.
Matsen III, F, Fu FH, and Hawkins RJ (editors) American Academy
of Orthopaedic Surgeons, Rosemont Ill 1993.
10 Perlmutter GS, Sabbagg K, Apruzzese W, Cagliero E, Nathan D.
Adhesive Capsulitis of the Shoulder: A Comprehensive Study.  Ortho
J Harvard Med School 2001; 3:100-2.
11 Boyle-Walker KL, Gabard DL, Bietsch E, Masek-VanArsdale DM,
Robinson BL.  A profile of patients with adhesive capsulitis.  J Hand
Ther 1997; 10(3):222-8.
12 Modesto C, Crespo E, Villas C, Aquerreta D.  Adhesive capsulitis.  Is
it possible in childhood?  Scand J Rheumatol 1995; 24:255-6.
13 Hirschhorn P, Schmidt JM.  Frozen shoulder in identical twins.  Joint
Bone Spine 2000; 67(1):75-6.
14 Scarlat MM, Goldberg BA, Harryman DT 2nd.  Frozen shoulder in
diabetic patients: handle with care; higher incidence suggests the need
for early intervention.  J Musculoskel Med 2000; 17(8):484-8, 494-8.
15 Siegel, Cohen NJ, Gall EP.  Adhesive Capsulitis: A Sticky Issue.
American Family Physician 1999; 59(7):1843-52.
16 Burke MC, Brinan K, Kopp DE, et al.  Frozen shoulder syndrome
associated with subpectoral defibrillator implantation.  J Interv Card
Electrophysiol 1999; 3(3):253-6.
17 Tanishima T, Yoshimasu N.  Development and prevention of frozen
shoulder after acute aneurysm surgery.  Surg Neurol 1997; 48(1):19-
22.
18 Pineda C, Beatriz A, Martinez-Lavin M, Dabague J.  Frozen shoulder
triggred by cardiac catheterization via the Brachial artery.  Am J Med
1994; 96(1):90-1.
19 Franck JL, Beurrier P.  Can fulnarizine induce frozen shoulder?  Rev
Rhum (Engl Ed) 1996; 63(6):457.
20 Hutchinson JW, Tierney GM, Parsons SL, Davis TR.  Dupuytren’s
disease and frozen shoulder induced by treatment with a matrix
metalloprotinase inhibitor.  J Bone Joint Surg Br 1998; 80(5):907-8.
21 Zabraniecki L, Boub A, Mularcyzyk M, et al.  Frozen shoulder: a new
delayed complication of protease inhibitor therapy?  Rev Rhum Eng
Ed 1998; 65(1):72-4.
22 Grasland A, Ziza JM, Raguin G, Pouchot J, Vinceneux P.  Adhesive
capsulitis of shoulder and treatment with protease inhibitors in patients
with human immunodeficiency virus infection: report of 8 cases. J
Rheumatol 2000; 27(11):2642-6.
23 Wohlgethan JR.  Frozen shoulder in hyperthyroidism.  Arthritis Rheum
1987; 30(8):936-9.
24 McGory BJ, Endrizzi DP.  Adhesive capsulitis of the hip after bilateral
adhesive capsulitis of the shoulder.  Am J Orthop 2000; 29(6):457-
60.
25 Simotas AC, Tsairis P.  Adhesive capsulitis of the glenohumeral joint
with an unusual neuropathic presentation: a case report.  Am J Phys
Med Rehabil 1999; 78(6):577-81.
26 Bunker TD, Anthony PP.  The pathology of frozen shoulder: A
Dupuytren-like disease.  J Bone Joint Surg Br 1995; 77(5):677-83.
27 Smith SP, Devaraj VS, Bunker TD.  The association between frozen
shoulder and Dupuytren’s disease.  J Shoulder Elbow Surg 2001;
10(2):149-51.
28 Bunker TD, Esler CN.  Frozen shoulder and lipids.  J Bone Joint Surg
Br 1995; 77(5):684-6.
29 Fleming A, Dodman S, Beer TC, Crown S.  Personality in frozen
shoulder.  Ann Rheumatol Dis 1976; 35:456-7.
30 Wright V, Haq AM.  Periarthritis of the shoulder. I.  Aetiological
considerations with particular reference to personality factors.  Annals
of the Rheumatic Diseases 1976; 35:213-9.
31 Klinger HM, Otto S, Baums MH, Haerer T.  Early arthroscopic release
in refractory shoulder stiffness. Arch Orthop Trauma Surg 2002;
122(4):200-3.
Frozen Shoulder/Hydrodilatation - A Case Series
SIMPSON / BUDGE34
32 Braudy R.  The Frozen Shoulder Conundrum.  AzPTA Update 2003;
February:4.
33 Reeves B.  The natural history of the frozen shoulder syndrome.  Scand
J Rheumatol 1975; 4(4):193-6.
34 Shaffer B, Tibone TE, Kerlan RK.  Frozen Shoulder Syndrome: A
Long Term Follow-up.  J Bone Joint Surg 1992; 74A:738-46.
35 Sandor R.  Adhesive Capsulitis: Optimal Treatment of ‘Frozen
Shoulder’.  The Physician and Sports Medicine 2000; 28(9).  Available
at URL: http://www.physsportsmed.com/issues/2000/09_00/
sandor.htm accessed: 15/12/03.
36 Neviaser RJ, Neviaser TJ.  The Frozen Shoulder.  Diagnosis and
Management.  Clinical Orthopaedics and Related Research 1987;
223:59-64.
37 Hannafin JA.  Arthroscopic Findings and Treatement of the Frozen
Shoulder.  ShoulderScope – Library 1999.  Available at URL:
www.shoulder.com/hannafin_frozenshoulder.pdf accessed: 22/12/03.
38 Ozaki J.  Pathomechanics and operative managment of chronic frozen
shoulder.  Ann Chir Gynaecol 1996; 85(2):156-8.
39 Bunker TD, Reilly J, Baird KS, Hamblen DL.  Expression of growth
factors, cytokines and matrix metalloproteinases in frozen shoulder.
J Bone Joint Surg Br 2000; 82(5):768-73.
40 Pawl RP.  Crontroversies surrounding reflex sympathetic dystrophy:
a review article.  Curr Rev Pain 2000; 4(4):259-67.
41 Bertilson BC, Grunnesjö DN, Strender L-E.  Reliability of Clinical
Tests in the Assessment of Patients With Neck/Shoulder Problems -
Impact of History.  SPINE 2003; 28(19):2222-31.
42 Spindler KP, Dovan TT.  Assessment and Management of the Painful
Shoulder.  Clin Conerstone 2001; 3(5):26-37.
43 Leppala J, Kannus P, Sievanen H, Jarvinen M, Vuori I.  Adhesive
capsulitis of the shoulder (frozen shoulder) produces bone loss in the
affected humerus, but long-term bony recovery is good.  Bone 1998;
22(6):691-4.
44 Okamura K, Ozaki J.  Bone mineral density of the shoulder joint in
frozen shoulder.  Orch Orthop Trauma Surg 1999; 119(7-8):363-7.
45 Loyd JA, Loyd HM.  Adhesive capsulitis of the shoulder: arthrographic
diagnosis and treatment.  South Med J 1983; 76(7):879-83.
46 Esposito S, Ragozzino A, Russo R, Minelli S, Tuccillo M.
Arthrography in the diagnosis and treatment of idiopathic adhesive
capsulitis.  Radiol Med 1993; 85(5):583-7.
47 Ryu KN, Lee SW, Rhee YG, Lim JH.  Adhesive capsulitis of the
shoulder joint: usefulness of dynamic sonography.  J Ultrasound Med
1993; 12(8):445-9.
48 Emig EW, Schweitzer ME, Karasick D, Lubowitz J.  Adhesive
capsulitis of the shoulder: MR diagnosis.  Am J Roentgenol 1995;
164(6):1457-9.
49 Manton GL, Schweitzer ME, Weishaupt D, Karasick D.  Utility of
MR arthrography in the diagnosis of adhesive capsulitis.  Skeletal
Radiol 2001; 30(6):326-30.
50 Lee MH, Ahn JM, Muhle C, et al.  Adhesive capsulitis of the shoulder:
diagnosis using magnetic resonance arthrography, with arthroscopic
findings as the standard.  J Comput Assist Tomogr 2003; 27(6):901-
6.
51 Connell D, Padmanabhan R, Buchbinder R.  Adhesive capsulitis: role
of MR imaging in differential diagnosis.  Eur Radiol 2002;
12(8):2100-6.
52 Carrillon Y, Noel E, Fantino O, Perrin-Fayolle O, Tran-Minh VA.
Magnetic resonance imaging findings in idiopathic adhesive capsulitis
of the shoulder.  Rev Rhum (Engl Ed) 1999; 66(4):201-6.
53 Robinson D, Halperin N, Agar G, Alk D, Rami K.  Shoulder girdle
neoplasms mimicking frozen shoulder syndrome.  J Shoulder Elbow
Surg 2003; 12(5):451-5.
54 Petchkrua W, Harris SA.  Shoulder pain as an unusual presentation of
pneumonia in a stroke patient: a case report.  Arch Phys Med Rehabil
2000; 81(6):827-9.
55 Lippitt SB, Harryman DT, Matsen FA 3rd.  A practical tool for
evaluating function: The simple shoulder test.  In: The Shoulder: A
Balance of Mobility and Stability: workshop, Vail Colorado,
September 1992. Matsen FA 3rd, Fu FH, and Hawkins RJ (eds) (1993)
Rosemont, IL: American Academy of Orthopaedic Surgeons.
56 Matsen FA 3rd, Lippitt SB, Sidles JA, Harryman DT 2nd.  Practical
evaluation and management of the shoulder.  WB Sanders,
Philadelphia 1994.
57 Beaton DE, Richards RR.  Measuring function of the shoulder.  A
cross-sectional comparison of five questionnaires.  J Bone Joint Surg
Am 1996; 78(6):882-90.
58 Beaton D, Richards RR.  Assessing the reliability and responsiveness
of 5 shoulder questionnaires.  J Shoulder Elbow Surg 1998; 7(6):565-
72.
59 Harryman DT 2nd, Matsen FA 3rd, Sidles JA.  Arthroscopic
management of refractory shoulder stiffness.  Arthroscopy 1997;
13(2):133-47.
60 Noel E, Thomas T, Schaeverbeke T, Thomas P, Bonjean M, Revel M.
Frozen Shoulder.  Joint Bone Spine 2000; 67(5):393-400.
61 Dodenhoff RM, Levy O, Wilson A, Copeland SA.  Manipulation under
anaesthesia for primary frozen shoulder: effect on early recovery and
return to activity.  J Shoulder Elbow Surg 2000; 9(1):23-6.
62 Griggs SM, Ahn A, Green A.  Idiopathic adhesive capsulitis. A
prospective functional outcome study of nonoperative treatment.  J
Bone Joint Surg Am 2000; 82-A(10):1398-407.
63 Rizk TE, Christopher RP, Pinals RS, Higgins AC, Friz R.  Adhesive
capsulitis (frozen shoulder): a new approach to its management.  Arch
Phys Med Rehabil 1983; 64(1):29-33.
64 Hamer J, Kirk JA.  Physiotherapy and the frozen shoulder: a
comparative trial of ice and ultrasonic therapy.  NZ Med J 1976;
83:191-2.
65 Miller MD, Wirth MA, Rockwood CA Jr.  Thawing the frozen shoulder:
the’patient’ patient.  Orthopaedics 1996; 19(10):849-53.
66 Liaw SC.  The effect of timing of physiotherapy on change in range
of motion and function in frozen shoulder.  Physiotherapy – Singapore
2000; 3(3):82-6.
67 Mao CY, Jaw WC, Cheng HC.  Frozen shoulder: correlation between
the response to physical therapy and follow-up shoulder arthrography.
Arch Phys Med Rehabil 1997; 78(8):857-9.
68 Vermeulen HM, Obermann WR, Burger BJ, Kok GJ, et al.  End-range
mobilization techniques in adhesive capsulitis of the shoulder joint:
A multiple-subject case report.  Physical Therapy 2000; 80(12):1204-
13.
69 Cleland J, Durall CJ.  Physical therapy for adhesive capsulitis:
systematic review.  Physiotherapy 2002; 88(8):450-7.
70 Green S, Buchbinder R, Hetrick S.  Physiotherapy interventions for
shoulder pain (Cochrane Review).  The Cochrane Library Issue 2
Update Software 2004.  Chichester, UK: John Wiley & Sons, Ltd.
71 Binder A, Hasleman BI, Barr G, et al.  A controlled study of oral
prednisolone in frozen shoulder.  Br J Rheumatol 1986; 25(3):288-
92.
72 Rizk TE, Pinals RS, Talaiver AS.  Corticosteroid injections in adhesive
capsulitis: investigation of their value and site.  Arch Phys Med Rehabil
1991; 72(1):20-2.
73 Gam AN, Schydilowsky P, Rossel I, Remvig L, Jensen EM.  Treatment
of ‘frozen shoulder’ with distension and glucocorticoid compared with
glucocorticoid alone.  Scand J Rheumatol 1998; 27(6):425-30.
74 Carette S, Moffet H, Tardif J, et al.  Intraarticular Corticosteroids,
Supervised Physiotherapy, or a Combination of the Two in the
Treatment of Adhesive Capsulitis of the Shoulder.  A Placebo-
Controlled Trial.  Arthritis & Rheumatism 2003; 48(3):829-38.
75 Buchbinder R, Green S, Youd JM.  Corticosteroid injections for
shoulder pain (Cochrane Review).  The Cochrane Library Issue 2
Update Software 2004.  Chichester, UK: John Wiley & Sons, Ltd.
Frozen Shoulder/Hydrodilatation - A Case Series
SIMPSON / BUDGE35 Volume 12 • Number 1 • July 2004 | ACO
76 Sharma RK, Bajekal RA, Bhan S.  Frozen shoulder syndrome. A
comparison of hydraulic distension and manipulation.  Int Orthop
1993; 17(5):275-8.
77 Reichmister JP, Friedman SL.  Long-term functional results after
manipulation of the frozen shoulder.  Md Med J 1999; 48(1):7-11.
78 Kivimaki J, Pohjolainen T.  Manipulation under anesthesia for frozen
shoulder with and without steroid injection.  Arch Phys Med Rehabil
2001; 82(9):1188-90.
79 Othman A, Taylor G.  Manipulation under anaesthesis for frozen
shoulder.  Int Orthop 2002; 26(5):268-70.
80 Massoud SN, Pearse EO, Levy O, Copeland SA.  Operative
management of the frozen shoulder in patients with diabetes.  J
Shoulder Elbow Surg 2002; 11(6):609-13.
81 Hamdan TA, Al-Essa KA.  Manipulation under anaesthesia for frozen
shoulder.  Int Orthop 2003; 27(2):107-9.
82 Watson L, Dalziel R, Story I.  Frozen Shoulder: a 12-month clinical
outcome trial.  J Shoulder Elbow Surg 2000; 9(1):16-22.
83 Chen SK, Chien Sh, Fu Yc, Huang PJ, Chou PH.  Idiopathic frozen
shoulder treated by arthroscopic brisement.  Kaohsiung J Med Sci
2002; 18(6):289-94.
84 Gerber C, Espinosa N, Perren TG.  Arthroscopic treatment of shoulder
stiffness.  Clin Orthop 2001; 390:119-28.
85 Omari A, Bunker TD.  Open surgical release for frozen shoulder:
surgical findings and results of the release.  J Shoulder Elbow Surg
2001; 10(4):353-7.
86 Chambler AFW, Carr AJ.  Aspects of current management: The role
of surgery in frozen shoulder.  J Bone & Joint Surg 2003; 85(6):789-
95.
87 Jones DA, Chattopadhyay C.  Suprascapular nerve block for the
treatment of frozen shoulder in primary care: a randomized trial.  Br J
Gen Pract 1999; 49(438):39-41.
88 Andren L, Lundberg B.  Treatment of rigid shoulders by joint
distension during arthrography.  Acta Orthop Scand 1965; 36:45-53.
89 Hsu SY, Chan KM.  Arthroscopic distension in the management of
frozen shoulder.  Int Orthop 1991; 15(2):79-83.
90 Ekelund AL, Rydell N.  Combination treatment for adhesive capsulitis.
Clin Orthop 1992; 282:105-9.
91 Fareed DO, Gallivan WR Jr.  Office management of frozen shoulder
syndrome.  Treatment with hydraulic distension under local
anaesthesia.  Clin Orthop 1989; 242:177-83.
92 Mulcahy KA, Baxter AD, Oni OO, Finlay D.  The value of shoulder
distension arthrography with intraarticular injection of steroid and
local anaesthetic: a follow-up study.  Br J Radiol 1994; 67(795):263-
6.
93 Gavant ML, Rizk TE, Gold RE, Flick RA.  Distension arthrography
in the treatment of adhesive capsulitis of the shoulder. (1994) J Vasc
Interv Radiol 1994; 5(2):305-8.
94 Rizk TE, Gavant ML, Pinals RS.  Treatment of adhesive capsulitis
(frozen shoulder) with arthrographic capsular distension and rupture.
Arch Phys Med Rehabil 1994; 75(7):803-7.
95 van Royen BJ, Pavlov PW.  Treatment of frozen shoulder by distension
and manipulation under local anaesthesia.  Int Orthop 1996;
20(4):207-10.
96 Morgan B, Jones AR, Mulcahy KA, Finlay DB, Collett B.
Transcutaneous electric nerve stimulation (TENS) during distension
shoulder arthrography: a controlled trial.  Pain 1996; 64(2):265-7.
97 Wybier M, Parlier-Cuau C, Baque MC, Champsaur P, Haddad A,
Laredo JD.  Distension Arthrography in Frozen Shoulder Syndrome.
Semin Musculoskelet Radiol 1997; 1(2):251-6.
98 Parler-Cuau C, Champsaur P, Nizard R, Wybier M, Bacque MC,
Laredo JD.  Percutaneous treatments of painful shoulder.  Radiol Clin
North Am 1998; 36(3):589-96.
99 Laroche M, Ighilahriz O, Moulinier L, Constantin A, Cantagrel A,
Mazieres B.  Adhesive capsulitis of the shoulder: an open study of 40
cases treated by joint distention during arthrography followed by an
intraarticular corticosteroid injection and immediate physical therapy.
Rev Rhum Engl Ed 1998; 65(5):313-9.
100 Halverson L, Maas R.  Shoulder joint capsule distension (hydroplasty):
a case series of patients with ‘frozen shoulders’ treated in a primary
care office.  J Fan Pract 2002; 51(1):61-3.
101 Bell S, Coghlan J, Richardson M.  Hydrodilatation in the management
of shoulder capsulitis.  Australasian Radiology 2003; 47:247-51.
102 Vad VB, Sakalkale D, Warren RF.  The role of capsular distention in
adhesive capsulitis.  Arch Phys Med Rehabil 2003; 84(9):1290-2.
103 Jacobs LGH, Barton MAJ, Wallace WA, Ferrousis J, Bunn NA,
Bossingham DH.  Intra-articular distension and steroids in the
management of capsulitis of the shoulder.  BMJ 1991; 302:1498-501.
104 Corbeil V, Dussault R, Leduc B, Fleury J.  Capsulite retractile de
l’epaule: etude comparitive de l’arthrograpie avec corticotherape intra-
articulaire avec ou sans distension capsulaire.  J Can Assoc Radiol
1992; 43:127-30.
105 Callinan N, McPherson S, Cleaveland S, et al.  Effectiveness of
hydroplasty and therapeutic exercise for treatment of frozen shoulder.
J Hand Therapy 2003; 16(3):219-24.
106 Morency G, Dussault RG, Robillard P, Samson L.  Distention
arthrography in the treatment of adhesive capsulitis of the shoulder.
[article in French].  Can Assoc Radiol J 1989; 40(2):84-6.
107 Buchbinder R, Green S, Forbes A, Hall S, Lawler G.  Arthrographic
joint distension with saline and steroid improves function and reduces
pain in patients with painful stiff shoulder: results of a randomised,
double blind, placebo controlled trial.  Ann Rheum Dis 2004; 63:302-
9.
108 Tanaka T, Umeshaki N, Ogita S.  Thawing of frozen shoulder in
menopausal women treated with a Japanese herbal medicine, Kanzo-
to extract: report of two cases.  Clin Esp Obstet Gynecol 2000;
27(1):14-6.
109 Carter B.  Client’s experiences of frozen shoulder and its treatment
with Bowen technique.  Complement Ther Nurs Midwifery 2002;
8(4):204-10.
110 Sun KO, Chan KC, Lo SL, Fong DY.  Acupuncture for frozen shoulder.
Hong Kong Med J 2001; 7(4):381-91.
111 Wiesl JT, Niel-Asher S, Latham M, Hazleman BL, Speed CA.  A Pilot
Randomised Placebo Controlled Trial of Physiotherapy and
Osteopathic Treatment for Frozen Shoulder.  Br J Rheumatol 42,
Suppliment 1:Article 2003; 418:146.
112 Polkinghorn BS.  Chiropractic treatment of frozen shoulder syndrome
(adhesive capsulitis) utilizing mechanical force, manually assisted
short lever adjusting procedures.  J Manipulative Physiol Ther 1995;
18(2):105-15.
113 Viola RW, Boatright KC, Smith KL, Sidles JA, Matsen FA III.  Do
shoulder patients insured by workers’ compensation present with worse
self-assessed function and health status?  J Shoulder Elbos Surg 2000;
9(5):368-72.
114 Green S, Buchbinder R, Glazier R, Forbes A.  Interventions for
shoulder pain (Cochrane Review).  The Cochrane Library 2004; Issue
2 Update Software.  Chichester, UK: John Wiley & Sons, Ltd.
115 Neviaser TJ.  Adhesive capsulitis.  Orthop Clin North Am 1987;
18(3):439-43.
Frozen Shoulder/Hydrodilatation - A Case Series
SIMPSON / BUDGE